Direvo Biotech AG Acquires AC Biotec

DIREVO Biotech AG, a leading company for superior bioengineered products and processes for industrial and pharmaceutical applications, announced today that it has acquired AC Biotec GmbH in an all cash transaction. AC Biotech will continue to operate as an independent, fully-owned subsidiary of Direvo Biotech with Dr. Simon Curvers continuing as Managing Director. This acquisition helps Direvo extend and expand its capabilities and offerings to its current customers as well to new customers in the industrial biotechnology and pharmaceutical markets.